Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
TYPE 1.5 Diabetes LADA & MODY Dr KURIAN JOSEPH SMALL TOPIC PRESENTATIONS
<ul><li>MODY </li></ul>
Maturity-Onset Diabetes of the Young (MODY) 1975 Definition <ul><li>Type-2 diabetes mellitus in the young   plus </li></ul...
Current Definition of MODY <ul><li>Heterozygous  monogenic  mutations in </li></ul><ul><li>  one of the 6 different genes ...
Monogenic Forms of Diabetes <ul><li>Forms Associated with  Insulin Resistance  </li></ul><ul><li>Forms Associated with   D...
 
MODY-Related Proteins  [1/4] <ul><li>  Glucokinase </li></ul><ul><ul><li>Expressed in   -cells and liver </li></ul></ul><...
<ul><li>Liver-enriched transcription factors    HNF-1  , HNF-1  , and HNF-4  </li></ul><ul><ul><li>Expressed in liver, ...
MODY-Related Proteins  <ul><li>Transcription factor IPF-1 </li></ul><ul><ul><li>Expressed in pancreatic islets </li></ul><...
MODY-Related Proteins  <ul><li>Transcription factor Neuro-D1 (BETA2) </li></ul><ul><ul><li>Rare </li></ul></ul><ul><ul><li...
Phenotypic Expression and Natural History of MODY <ul><li>Recognition at young age </li></ul><ul><ul><li>1.Mild, asymptoma...
<ul><li>When to suspect MODY </li></ul><ul><li>a “type 1″ diabetes patient who has negative blood testing for autoantibodi...
Genetic Testing <ul><li>Only definitive way to confirm MODY </li></ul><ul><li>  blood or saliva  </li></ul><ul><li>Not all...
Rx for MODY <ul><li>Rx depends on the involved gene and other factors </li></ul><ul><li>MODY 3 and 1 can be treated initia...
<ul><li>  LADA </li></ul><ul><li>TYPE 1.5 DIABETES </li></ul>
LATENT AUTOIMMUNE DIABETES OF ADULTHOOD <ul><li>Late-onset autoimmune diabetes of adulthood </li></ul><ul><li>Slow Onset T...
Characteristics of LADA <ul><li>Adult age (usually over 30 years) at time of diagnosis </li></ul><ul><li>May initially app...
Criteria for LADA <ul><li>Aged at least 30 years or older </li></ul><ul><li>Positive for at least one of the auto-antibodi...
LADA Vs T2DM <ul><li>C-peptid levels </li></ul><ul><li>LADA have low level VS  Normal or high in T2DM </li></ul><ul><li>Gl...
Diagnosis <ul><li>Performing a GAD antibody test is the most common method of diagnosing LADA.  </li></ul><ul><li>Islet ce...
Management <ul><li>LADA often does not require insulin at the time of diagnosis and may be managed with diet and exercise....
<ul><li>Thank you </li></ul>
 
Monogenic Forms of Diabetes <ul><li>Forms Associated with Insulin Resistance  </li></ul><ul><ul><ul><li>Mutation in the in...
MODY  <ul><li>Associated with Defective Insulin Secretion </li></ul><ul><li>HNF-4 α  (MODY 1) </li></ul><ul><li>Glucokinas...
MODY Vs T2DM <ul><li>Mode of inheritance </li></ul><ul><ul><li>MODY: Monogenic, autosomal dominant </li></ul></ul><ul><ul>...
Distinguishing Clinical Characteristics of MODY and Type 2 Diabetes   [2/2] <ul><li>Penetrance </li></ul><ul><ul><li>MODY:...
 
Investigations <ul><li>MODY should be considered in patients with 1.non-ketotic diabetes at presentation </li></ul><ul><li...
MODY vs T2DM <ul><li>Prominent family history of diabetes in 2-3 generations  </li></ul><ul><li>Childhood, adolescence, us...
Upcoming SlideShare
Loading in …5
×

LADA & MODY DIABETES

31,764 views

Published on

Published in: Health & Medicine

LADA & MODY DIABETES

  1. 1. TYPE 1.5 Diabetes LADA & MODY Dr KURIAN JOSEPH SMALL TOPIC PRESENTATIONS
  2. 2. <ul><li>MODY </li></ul>
  3. 3. Maturity-Onset Diabetes of the Young (MODY) 1975 Definition <ul><li>Type-2 diabetes mellitus in the young plus </li></ul><ul><li>Autosomal dominant inheritance </li></ul>
  4. 4. Current Definition of MODY <ul><li>Heterozygous monogenic mutations in </li></ul><ul><li> one of the 6 different genes </li></ul><ul><li>Autosomal dominant inheritance </li></ul><ul><li>Onset of diabetes early in life: childhood, adolescence or young adulthood </li></ul><ul><li>Primary defect in insulin secretion </li></ul>
  5. 5. Monogenic Forms of Diabetes <ul><li>Forms Associated with Insulin Resistance </li></ul><ul><li>Forms Associated with Defective Insulin Secretion </li></ul><ul><li>Maturity-Onset diabetes of the young (MODY) </li></ul><ul><li>HNF-4 α (MODY 1) </li></ul><ul><li>Glucokinase (MODY 2) </li></ul><ul><li>HNF-1 α (MODY 3) </li></ul><ul><li>IPF (MODY 4) </li></ul><ul><li>HNF-1 β (MODY 5) </li></ul><ul><li>NeuroD1/BETA2 (MODY 6) </li></ul>
  6. 7. MODY-Related Proteins [1/4] <ul><li> Glucokinase </li></ul><ul><ul><li>Expressed in  -cells and liver </li></ul></ul><ul><ul><li>GSK catalyzes the formation of glucose-6-phosphate from glucose. </li></ul></ul><ul><ul><li>Beta cells - “Glucose sensor” Control rate of Glucose phosphorylation </li></ul></ul><ul><ul><li>Liver – Helps in storage of glucose as glycogen </li></ul></ul><ul><ul><li>Mild stable hyperglycemia </li></ul></ul><ul><ul><li>Does not respond to Sulfonylureas. </li></ul></ul>
  7. 8. <ul><li>Liver-enriched transcription factors HNF-1  , HNF-1  , and HNF-4  </li></ul><ul><ul><li>Expressed in liver, pancreatic islets, kidneys and genitalia. </li></ul></ul><ul><ul><li>In Beta cells they regulate </li></ul></ul><ul><ul><li>The expression of the insulin gene Proteins involved in glucose transport and metabolism. </li></ul></ul><ul><ul><li>Mutations results in defect of insulin secretion response to glucose, leading to progressive decline in glycemic control. </li></ul></ul><ul><ul><li>MODY 1 &3 responds to sulfonylurea initially. </li></ul></ul>
  8. 9. MODY-Related Proteins <ul><li>Transcription factor IPF-1 </li></ul><ul><ul><li>Expressed in pancreatic islets </li></ul></ul><ul><ul><li>Central role in development of pancreas. </li></ul></ul><ul><ul><li>Mediates glucose-induced stimulation of insulin-gene transcription </li></ul></ul><ul><ul><li>Exocrine pancreatic insufficiency may occur. </li></ul></ul>
  9. 10. MODY-Related Proteins <ul><li>Transcription factor Neuro-D1 (BETA2) </li></ul><ul><ul><li>Rare </li></ul></ul><ul><ul><li>Expressed in pancreatic islets </li></ul></ul><ul><ul><li>Activates the transcription of the insulin gene </li></ul></ul><ul><ul><li>Required for normal development of the pancreatic islets </li></ul></ul>
  10. 11. Phenotypic Expression and Natural History of MODY <ul><li>Recognition at young age </li></ul><ul><ul><li>1.Mild, asymptomatic increase in blood glucose in a child, adolescent or young adult(<25 years) </li></ul></ul><ul><li>2. Prominent family history of diabetes in 2-3 generations </li></ul><ul><li> 3. Usually not associated with obesity </li></ul><ul><li>Not progressive, or slowly progressive hyperglycemia </li></ul><ul><ul><li>Hyperglycemia responsive to diet and/or oral anti-hyperglycemic agents for years to decades </li></ul></ul>
  11. 12. <ul><li>When to suspect MODY </li></ul><ul><li>a “type 1″ diabetes patient who has negative blood testing for autoantibodies. </li></ul><ul><li>a “type 1″ diabetes patient who generates a significant amount of insulin for years beyond diagnosis (detectable blood levels of c-peptide, proinsulin, and/ or insulin) </li></ul><ul><li>a “type 2″ diabetes patient who is normal weight and shows no signs of insulin resistance. </li></ul><ul><li>a diabetes with family history of early onset diabetes for 2-3 generations. </li></ul><ul><li>Diabetes paired with pancreatic insufficiency  </li></ul><ul><li>Individual or family history of diabetes paired with developmental kidney disease or kidney cysts </li></ul>
  12. 13. Genetic Testing <ul><li>Only definitive way to confirm MODY </li></ul><ul><li>  blood or saliva  </li></ul><ul><li>Not all mutations cause diabetes </li></ul><ul><li>Each child will have a 50% chance of inheriting the gene  </li></ul><ul><li>1 st degree relatives have a 50% chance of carrying the same gene mutation </li></ul><ul><li>Then they have  a >95% chance of developing MODY at some time in their life. </li></ul>
  13. 14. Rx for MODY <ul><li>Rx depends on the involved gene and other factors </li></ul><ul><li>MODY 3 and 1 can be treated initially with sulfonylureas, prompts the body to produce insulin. </li></ul><ul><li>Usually GCK-MODY requires no treatment at all. </li></ul><ul><li>Other type of MODY Rx is unclear may require multiple daily Insulin injections. </li></ul>
  14. 15. <ul><li> LADA </li></ul><ul><li>TYPE 1.5 DIABETES </li></ul>
  15. 16. LATENT AUTOIMMUNE DIABETES OF ADULTHOOD <ul><li>Late-onset autoimmune diabetes of adulthood </li></ul><ul><li>Slow Onset Type 1 diabetes </li></ul><ul><li>Type 1.5 diabetes - Type 1 diabetes develops in adults </li></ul><ul><li>Mistakenly diagnosed as T2DM </li></ul>
  16. 17. Characteristics of LADA <ul><li>Adult age (usually over 30 years) at time of diagnosis </li></ul><ul><li>May initially appear to be non-obese Type 2 diabetes </li></ul><ul><li>May initially be controlled with nutrition and exercise </li></ul><ul><li>Patient gradually becomes dependent on insulin </li></ul><ul><li>Positive for auto-antibodies </li></ul><ul><li>Low C-peptide levels in the body </li></ul><ul><li>Often does not have a family history of Type 2 diabetes </li></ul>
  17. 18. Criteria for LADA <ul><li>Aged at least 30 years or older </li></ul><ul><li>Positive for at least one of the auto-antibodies found in type 1 diabetes </li></ul><ul><li>Free from insulin treatment for the first six months after diagnosis. </li></ul><ul><li>20% of persons diagnosed as having non-obesity-related type 2 diabetes may actually have LADA </li></ul>
  18. 19. LADA Vs T2DM <ul><li>C-peptid levels </li></ul><ul><li>LADA have low level VS Normal or high in T2DM </li></ul><ul><li>Glutamic acid decarboxylase(GAD) autoantibodies – Common in T1DM </li></ul><ul><li>Early age of onset </li></ul><ul><li>Non obese individuals </li></ul><ul><li>No family history of early onset diabetes </li></ul><ul><li>Ketosis prone </li></ul><ul><li>May requires insulin after initial 6 months </li></ul>
  19. 20. Diagnosis <ul><li>Performing a GAD antibody test is the most common method of diagnosing LADA. </li></ul><ul><li>Islet cell antibodies (ICA) are also common. </li></ul>
  20. 21. Management <ul><li>LADA often does not require insulin at the time of diagnosis and may be managed with diet and exercise. </li></ul><ul><li>  Due to destruction of the β-cells, they become insulin dependent more rapidly than “classic” type 2 diabetes </li></ul><ul><li>May require multiple daily Insulin injections(after 6 months) </li></ul>
  21. 22. <ul><li>Thank you </li></ul>
  22. 24. Monogenic Forms of Diabetes <ul><li>Forms Associated with Insulin Resistance </li></ul><ul><ul><ul><li>Mutation in the insulin receptor gene </li></ul></ul></ul><ul><ul><ul><li>Type A insulin resistance </li></ul></ul></ul><ul><ul><ul><li>Leprechaunism </li></ul></ul></ul><ul><ul><ul><li>Rabson-Mendenhall Syndrome </li></ul></ul></ul><ul><ul><ul><li>Lipoatrophic diabetes </li></ul></ul></ul><ul><ul><ul><li>Mutations in the PPAR γ gene </li></ul></ul></ul><ul><li>Forms Associated with Defective Insulin Secretion </li></ul><ul><li>Mutations in insulin or proinsulin genes </li></ul><ul><li>Mitochondrial gene mutations </li></ul><ul><li>Muturity-Onset diabetes of the young (MODY) </li></ul>
  23. 25. MODY <ul><li>Associated with Defective Insulin Secretion </li></ul><ul><li>HNF-4 α (MODY 1) </li></ul><ul><li>Glucokinase (MODY 2) </li></ul><ul><li>HNF-1 α (MODY 3) </li></ul><ul><li>IPF (MODY 4) </li></ul><ul><li>HNF-1 β (MODY 5) </li></ul><ul><li>NeuroD1/BETA2 (MODY 6) </li></ul>
  24. 26. MODY Vs T2DM <ul><li>Mode of inheritance </li></ul><ul><ul><li>MODY: Monogenic, autosomal dominant </li></ul></ul><ul><ul><li>DM2: Polygenic </li></ul></ul><ul><li>Age of onset </li></ul><ul><ul><li>MODY: Childhood, adolescence, usually <25 years </li></ul></ul><ul><ul><li>DM2: Usually 40-60 years; occasionally in obese adolescents </li></ul></ul><ul><li>Pedigree </li></ul><ul><ul><li>MODY: Multi-generational </li></ul></ul><ul><ul><li>DM2: Rarely multi-generational </li></ul></ul>
  25. 27. Distinguishing Clinical Characteristics of MODY and Type 2 Diabetes [2/2] <ul><li>Penetrance </li></ul><ul><ul><li>MODY: 80-95 % </li></ul></ul><ul><ul><li>DM2: Variable (10-40 %) </li></ul></ul><ul><li>Body habitus </li></ul><ul><ul><li>MODY: Not obese </li></ul></ul><ul><ul><li>DM2: Usually obese </li></ul></ul><ul><li>Dysmetabolic syndrome </li></ul><ul><ul><li>MODY: Absent </li></ul></ul><ul><ul><li>DM2: Usually present </li></ul></ul>
  26. 29. Investigations <ul><li>MODY should be considered in patients with 1.non-ketotic diabetes at presentation </li></ul><ul><li>2. Strong family history of diabetes mellitus without pancreatic auto-antibodies. </li></ul><ul><li>MODY Vs T2DM </li></ul><ul><li>  hyperinsulinaemia and high-normal c-peptide in T2DM </li></ul>
  27. 30. MODY vs T2DM <ul><li>Prominent family history of diabetes in 2-3 generations </li></ul><ul><li>Childhood, adolescence, usually <25 years </li></ul><ul><li>Usually not associated with obesity </li></ul>

×